Inovio Pharma (INO) Reports Q1 Loss of $0.30/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. NVDA
5. STZ
6. MSFT
7. SPY
8. SKYD
9. CRWV
10. IBM

Go back to Inovio Pharma (INO) Reports Q1 Loss of $0.30/Share

Inovio Pharmaceuticals Reports 2019 First Quarter Financial Results

May 9, 2019 4:05 PM EDT

PLYMOUTH MEETING, Pa., May 9, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO), an innovative biotechnology company focused on the discovery, development and commercialization of its synthetic nucleic technology targeted against cancers and infectious diseases, today reported financial results for the first quarter ended March 31, 2019. Inovio's management will host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss financial results and provide a general business update.

Inovio Highlights

VGX-3100/INO-3106; HPV-related Pre-cancersInovio's Phase 3 trials for VGX-3100, REVEAL 1 and REVEAL... More